UQCRHL: A Potential Drug Target and Biomarker (G440567)
UQCRHL: A Potential Drug Target and Biomarker
Unlike most proteins, UQCRHL ( Ubiquinol-Cytochrome c Reductase Hinge Protein Like ) is small, only 45 amino acids long, and yet it has a significant impact on cell biology. Its unique structure, which consists of a parallel beta-sheet and a hinge region, gives it a unique shape and function. UQCRHL is a protein that is involved in a critical cellular process called the ubiquinone biosynthesis pathway.
The ubiquinone biosynthesis pathway is a complex series of reactions that lead to the production of ubiquinone, a ubiquinone molecule that is found in almost all cells and plays a vital role in various cellular processes. The first step in this pathway is the reduction of ubiquinone to its biosynthetically active form, UQCRHL.
UQCRHL is a protein that is composed of two distinct domains: a N-terminal domain and a C-terminal domain. The N-terminal domain is responsible for the protein's unique shape and function. It contains a parallel beta-sheet, which is a unique feature in proteins. The beta-sheet is responsible for the protein's stability and plays a critical role in its function.
The C-terminal domain is responsible for the protein's stability and its ability to interact with other proteins. It contains a hinge region, which is a unique feature in proteins that allows them to interact with other proteins in a specific way. The hinge region is responsible for the protein's stability and plays a critical role in its function.
UQCRHL is a protein that is expressed in almost all cells and is involved in the ubiquinone biosynthesis pathway. It is also involved in the production of various proteins, including proteins that are involved in the production of new Ubiquinone molecules.
One of the key features of UQCRHL is its ability to interact with other proteins. It has been shown to interact with several proteins, including proteins that are involved in the production of new Ubiquinone molecules. This interaction between UQCRHL and other proteins is important for its function in the ubiquinone biosynthesis pathway.
Another feature of UQCRHL is its unique structure. Its parallel beta-sheet and hinge region give it a unique shape and function. The parallel beta-sheet is responsible for the protein's stability and plays a critical role in its function. The hinge region is responsible for the protein's stability and plays a critical role in its function.
UQCRHL is also involved in the regulation of cellular processes. It has been shown to be involved in the regulation of the cell cycle, the production of new proteins, and the regulation of the ubiquinone biosynthesis pathway.
Given its unique structure and its involvement in the production of essential proteins, UQCRHL is a protein that has the potential to be a drug target. Its unique structure and its involvement in the ubiquinone biosynthesis pathway make it an attractive target for drug development.
In conclusion, UQCRHL is a small protein that is involved in the production of essential proteins and the regulation of cellular processes. Its unique structure, which consists of a parallel beta-sheet and a hinge region, gives it a unique shape and function. As a result, UQCRHL has the potential to be a drug target and a biomarker. Further research is needed to fully understand its unique structure and its involvement in the ubiquinone biosynthesis pathway.
Protein Name: Ubiquinol-cytochrome C Reductase Hinge Protein Like
Functions: May be a component of the ubiquinol-cytochrome c reductase complex (complex III or cytochrome b-c1 complex), which is part of the mitochondrial respiratory chain. This protein may mediate formation of the complex between cytochromes c and c1
The "UQCRHL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UQCRHL comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
UQCRQ | URAD | URAHP | URB1 | URB1-AS1 | URB2 | Urea transporter | URGCP | URGCP-MRPS24 | URI1 | Uridine phosphorylase | URM1 | UROC1 | UROD | UROS | USB1 | USE1 | USF1 | USF2 | USF3 | USH1C | USH1G | USH2A | USHBP1 | USO1 | USP1 | USP1-UAF1 complex | USP10 | USP11 | USP12 | USP12-AS1 | USP12-DT | USP13 | USP14 | USP15 | USP16 | USP17L1 | USP17L10 | USP17L11 | USP17L12 | USP17L13 | USP17L14P | USP17L15 | USP17L17 | USP17L18 | USP17L2 | USP17L20 | USP17L21 | USP17L24 | USP17L25 | USP17L26 | USP17L27 | USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48
